First DOE Microbe Sequencing Project Grants Widely Hailed As Potential `Treasure Trove'

A recently established Department of Energy (DOE) initiative is expected to yield major scientific and commercial contributions as it embarks on its multimillion-dollar effort to sequence the entire genome of several free-living microorganisms. Scientists anticipate that the program will substantially expand understanding of evolutionary relationships, while it also advances genome-sequencing technology. Commercial application of the sequences, such as industrial enzymes used in cleaning up th

Written byKaren Young Kreeger
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Scientists anticipate that the program will substantially expand understanding of evolutionary relationships, while it also advances genome-sequencing technology. Commercial application of the sequences, such as industrial enzymes used in cleaning up the environment, is another benefit being espoused by the researchers.

Of the thousands of microbes found on Earth--each group with its potential scientific, medical, and commercial features of interest--how do funders and researchers choose which species to sequence first? Although the Department of Energy initially wanted to analyze a broader range of bugs, Microbial Genome Initiative project manager Jay Grimes says the investigators "made good arguments to do archaes [the Archaea] first." In part, he recounts, archaes were chosen because investigators would be able to sequence their genomes quickly. Their relatively small genomes of about 2 million base pairs--compared to the more than 3 billion in humans-- are helpful in that respect. Unique scientific and commercial aspects of archaes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo